The effect of Dexmedetomidine on Quality of Recovery after simple mastectomy under General anesthesia

Phase 2

Recruiting

• Conditions: Mastectomy.; Encounter for breast reconstruction following mastectomy; Z42.1

• Registration Number: IRCT20141009019470N100
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

Patients undergoing simple mastectomy surgery
Age 25-65 years
ASA Class I – II

Exclusion Criteria

History of heart failure
History of Kidney Failure
History of liver failure
Psychiatric and cognitive disorders
Chronic pain
Drug abuse or using psychotropic drugs
Pregnancy
Alcohol abuse
Long-term use of painkillers
History of allergy to dexmedetomidine
Redo surgery
History of motor disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The agitation. Timepoint: It is examined every 30 minutes for 2 hours in recovery as well as after the patient is transferred to ward every 2 to 6 hours. Method of measurement: Ramsay criteria.;Nausea and vomiting. Timepoint: It is examined every 30 minutes for 2 hours in recovery as well as after the patient is transferred to ward every 2 to 6 hours. Method of measurement: Likert.;Postoperative pain. Timepoint: It is examined every 30 minutes for 2 hours in recovery as well as after the patient is transferred to ward every 2 to 6 hours. Method of measurement: Visual analogue scale.